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study of HIV-1 transmitted drug resistance, filled question-
naires were obtained for 440 patients. Homosexual contact as
the most probable mode of HIV acquisition reported 326/440
patients. Subsequently, partial pol sequences were obtained for
252 MSM patients who were included in the present study.
Sequences were analyzed using the following automatic sub-
typing tools: REGA 2.0, REGA 3.0, COMET HIV-1 1.0, jpHMM, and
SCUEAL. Sequences that gave divergent subtyping results were
considered to be potential recombinant forms. Temporal trend
of the proportion of non-B and potential recombinant sequen-
ces (both combined termed as “non-pure subtype B” sequences)
was evaluated with Fisher exact test used for the assessment of
statistical significance. All five subtyping tools gave concordant
subtyping results in 230/252 (91.3%) of sequences. Pure subtype
B was assigned to 226/252 (89.7%) sequences and subtype A,
subtype C, subtype F and CRF01_AE were determined in one
patient each (0.4%). The remaining 22/252 (8.7%) sequences
yielded divergent results with at least one of the subtyping
tools, an indication to a possible recombination event in the
past. An increase in the proportion of “non-pure subtype B”
HIV-1 variants was noted over the years with 0% (95% confi-
dence interval (CI): 0–16%), 5% (95% CI: 1–15%), 4% (95% CI: 0–
13%), 11% (95% CI: 4–21%), and 25% (95% CI: 15–39%) determined
in the years 2000–2, 2003–5, 2006–8, 2009–11, and 2012–4, respec-
tively. The marked increase was on account of an increasing
number of potential recombinant sequences with subtype B as
one of the founder subtypes, since this subtype was identified
in 21/22 of divergent sequences. The remaining divergent
sequence was a complex recombinant containing subtypes D
and G. Additionally, all 4 pure non-B subtyped sequences were
determined in patients diagnosed in the last two years (2013–4).
The results obtained indicate that subtypes other than B are
entering the HIV-1 MSM epidemic in Slovenia, making recombi-
nation events among different subtypes more plausible. A
marked increase in the numbers of non-B subtypes and poten-
tial recombinant forms was observed among MSM in Slovenia
in recent years.
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There is limited information of patterns of protease inhibitor
(PI) resistance in adults failing second-line therapy. Next gener-
ation sequencing (NGS) detects drug resistance mutations as
low as 1%. However, the clinical implications of these minority
variants to treatment outcomes are still in debate.
Approximately 5% of antiretroviral treatment (ART) exposed
patients in our treatment program are on second-line boosted
protease inhibitor (PI). Population-based sequencing conducted
on some of these patients revealed no major HIV drug resist-
ance mutations (DRMs) to PIs. We compared population-based
sequencing and NGS results with the view of identifying
patterns of drug resistance mutations and minority variants.
Forty-eight plasma samples from 40 patients on second-line
NRTI/NNRTI and boosted PI regimens with evidence of virologic
failures (VL1,000 copies/ml) were used in this study. Of these,
eight were obtained at the time of first-line failure while the
remaining 40 at the time of second-line failure. Ultra-deep
sequencing sample preparation was achieved using Illumina
Nextera XT protocol. This required that target amplicon be sub-
jected to fragmentation, tagging, indexing, size exclusion bead
purification, normalization, and pooling. MiSeq data analysis
was performed using the Geneious software by applying 1% cut-
off at major drug resistance sites. Electropherogram data were
generated using ABI 3130 genetic analyzer and analysis per-
formed using Stanford Genotyping Resistance Interpretation
Algorithm available at http://sierra2.stanford.edu/sierra/servlet/
JSierra and IAS-USA 2015 Drug Resistance Interpretation list.
MiSeq sequencing showed that 53% (n¼ 23) of the patients
developed PI resistance, 93% (n¼ 40) had NRTI resistance, and
70% (n¼ 30) had NNRTI resistance. Of the DRMs detected in pro-
tease, L90M mutation was the most common mutation (28%,
n¼ 12) followed by L76V (21%, n¼ 9), then I47V (7%, n¼ 3) and
I84V (7%, n¼ 3). Among the NRTI associated mutations L74V
was the predominant mutation (77%, n¼ 33) followed by M184V/
I (60%, n¼ 26) then TAMS (51%, n¼ 22). Of these, 33% of patients
(n¼ 14) showed NRTIþNNRTI mutations, 39% (n¼ 17) showed
NRTIþNNRTIþPI mutations, 7% (n¼ 3) showed NRTIþPI muta-
tions, whereas 21% (n¼ 9) and 2.3% (n¼ 1) exclusively showed
NRTI and NNRTIs mutations respectively. Twenty-eight sam-
ples that had both MiSeq and Sanger sequencing data were
available for a comparison of mutational patterns in the PI
region. Miseq sequencing revealed minority PI mutations in 10
samples that were wild type by Sanger sequencing and one
sample showed mutations in both Sanger and NGS. The ten
samples revealing mutations based on MiSeq data comprised of
minority variants including L90M (50%, n¼ 5), L76V (20%, n¼ 2),
I50V (10%, n¼ 1), and N88S (20%, n¼ 2). Our data suggest that
even in the absence of PI mutations based on Sanger data, those
minority variants can be present. NGS revealed the presence of
PI resistance mutations in patients who had wild-type using
population-based sequencing. Given that patient regimen
revealed that minority variants were unlikely selected by ART
pressure, our results suggest poor adherence as the likely con-
tributor to second-line failure due to the high genetic barrier of
PIs. Since ART adherence in these patients was monitored using
clinico-immunological parameters and virological tests only
when treatment failure was suspected, our results suggest the
need for routine virological monitoring. This should provide
early opportunity for adherence intervention and thereby
avoiding the need for switch to salvage or third-line treatment
options, which is more expensive and not readily available in
our setting.
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Many human diseases are caused by emerging pathogens, such
as the SARS and MERS coronaviruses. Timely understanding of
the behaviors of these pathogens plays an important role in
helping doctors and scientists in searching for treatment meth-
ods and designing vaccines. The development of next-genera-
tion sequencing (NGS) has led to significant breakthroughs in
the production of large amount of unbiased DNA sequence data
from field and human clinical samples, providing the capacity
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to identify the sources of infection, and the virus evolution as
well as host/virus interaction. In our study, using 454/Illumina
sequencing, we have obtained large amount of whole genome
sequences. We designed a preliminary bioinformatics analysis
pipeline to classify these NGS reads. First we mapped
our nucleotide reads to GenBank reference sequences using
BLAST, and classified them by their taxonomic family, such as
host, virus and unclassified. Then, for a specific type of virus
(e.g. influenza virus, MERS coronavirus), we conducted de novo
and reference based assembly of the reads to obtain the full
genome sequences for further phylogenetic study. In the future,
through advanced bioinformatics tools, we hope to get more
detailed information from our large amount of NGS sequences
of field/clinical samples, experimental data, especially in the
following areas: (i) finding novel pathogens in unclassified
sequences; (ii) virus/virus interactions; (iii) pathogen/host
interaction.
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We report the first laboratory-confirmed case of Middle East
Respiratory Syndrome Coronavirus (MERS-CoV) infection from a
patient returning to the Philippines from the Kingdom of Saudi
Arabia (KSA). MERS-CoV was first identified in 2012 circulating
in Middle Eastern countries with outbreaks occurring in KSA,
the United Arab Emirates (UAE), and South Korea, plus sporadic
imported cases in at least 20 other countries. The Philippines is
at risk for MERS-CoV transmission from frequent travelers, such
as overseas Filipino workers and Hajj pilgrims, coming from
Middle Eastern countries. Throat swabs, sputum samples, and a
rectal swab were collected from the index case within 13 to 22
days after the onset of symptoms. MERS-CoV testing was per-
formed using a real-time reverse transcription polymerase
chain reaction (RT-qPCR) screening assay targeting regions
upstream of the envelope gene (upE) and the nucleocapsid gene
(N2), a confirmatory RT-qPCR assay targeting regions within the
open reading frame 1a gene (ORF1a) and another region of the N
gene (N3), and Sanger sequencing of regions of the N and RNA-
dependent polymerase (RdRp) genes. The index case tested
weakly positive for MERS-CoV in a sputum sample until day 19
of illness. Sequences of the N and RdRp gene regions reveal 100
and 99% similarity with MERS-CoV sequences obtained in KSA
and UAE, respectively, confirming that the infection originated
from Middle Eastern strains. Two unique synonymous/silent
mutations (T15259A and T15265C) were identified in the RdRp
sequence fragments. Whole genome sequencing of the strain
may identify other mutations across the genome and determine
the most probable origin of the strain.
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Detailed information on the source, spread and evolution of res-
piratory syncytial virus (RSV) during seasonal community out-
breaks remains sparse. Molecular analyses of attachment (G)
gene sequences from hospitalised cases suggest that multiple
genotypes and variants co-circulate during epidemics and that
RSV persistence over successive seasons is characterized by
replacement and multiple new introductions of variants. No
studies have defined the patterns of introduction, spread and
evolution of RSV at the local community and household level.
We present a whole genome sequence analysis of 131 RSV
group A viruses collected during six-month household-based
RSV infection surveillance in Coastal Kenya, 2010 within an
area of 12 km2. RSV infections were identified by regularly
screening of all household members twice weekly. Phylogenetic
analysis revealed that the RSV A viruses in 9 households were
closely related to genotype GA2 and fell within a single branch
on the global phylogeny. Genomic analysis allowed the detec-
tion of household-specific variation in seven households. For
comparison, using only G gene analysis, household-specific var-
iation was found only in 1 of the 9 households. Nucleotide
changes were observed intra-host (viruses identified from same
individual in follow-up sampling) and inter-host (viruses identi-
fied from different household members) and these coupled with
sampling dates enabled partial reconstruction of the within
household transmission chains. The genomic evolutionary rate
for the household dataset was estimated as 2.307 103 (95%
highest posterior density: 0.93513–4.1636 103) substitutions/
site/year. We conclude that (i) at the household level, most RSV
infections arise from the introduction of a single virus variant
followed by accumulation of household specific variants and (ii)
analysis of complete virus genomes is crucial to better under-
stand viral transmission in the community. A key question aris-
ing is whether prevention of RSV introduction or spread within
the household by vaccinating key household members in these
functions would lead to a reduced onward community wide
transmission.
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Reconstructing transmission chains for outbreaks is important
in understanding how viruses spread. Furthermore, defining
the main underlying determinants of transmission chains is
important for developing effective interventions. Whole
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